SLA 0.00% $3.34 silk laser australia limited

Maybe that's why the share price isn't being impacted by the...

  1. 580 Posts.
    Maybe that's why the share price isn't being impacted by the lack of Ropren approval - Bioeffective A is outperforming all on its own.

    I predict Solagran will merge with Neptune Marine Services to create a Bioeffective pipeline between Russia and the United States. The result will surely be the world's first trillion-dollar company.

    Buy now before it's too late.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.